false

Chronic Thromboembolic Pulmonary Hypertension Program

The Chronic Thromboembolic Pulmonary Hypertension Program offers advanced, focused, and comprehensive evaluation and treatment approaches for a subset of patients with pulmonary hypertension who experience recurring emboli (blood clots) in their lungs. Without effective treatment, this chronic disease can lead to life-threatening heart failure.
primary
phone
617-525-9733
6175259733

About the program

The Chronic Thromboembolic Pulmonary Hypertension Program (CTEPH) is one of only a handful of programs nationwide that offer a comprehensive collaboration of medical, interventional, and surgical care for this condition. By bringing together experts from cardiothoracic surgery, pulmonary medicine, interventional cardiology, and cardiovascular medicine, we are better able to deliver the most appropriate and effective care for our patients with CTEPH.

Part of Lung Care

What is CTEPH?

An embolus is a mass of platelets and proteins that gets lodged in a blood vessel and blocks blood flow. In most cases, these blockages are either broken down successfully with medication or the clot dissipates on its own. In some cases, however, medication is ineffective and/or the clots recur with increasing frequency.

When these clots go unresolved, a process of inflammation and scarring turns these clots into blockages that are even harder to eliminate with conventional treatments. This leads to a form of pulmonary hypertension (high blood pressure in the blood vessels of the lungs) that is chronic and extremely dangerous.

Our approach

Evaluation

The primary symptom of CTEPH is an unexplained shortness of breath (dyspnea), which can be attributed to a wide variety of conditions. As a result, CTEPH is often misdiagnosed as one of these other conditions or is left undiagnosed.

As the disease progresses, other symptoms may appear, including:

  • difficulty breathing
  • water retention in the limbs (edema)
  • swelling or bloating of the abdomen
  • chest pain
  • light-headedness

We use advanced diagnostic testing to determine whether patients have unresolved clotting in their lungs (CTEPH) or common pulmonary hypertension. We typically perform a right heart catheterization (to measure blood flow) and computed tomographic (CT) imaging of the pulmonary blood vessels and pulmonary arteries. This advanced testing also gives us a clearer picture of the nature of the disease, such as where it’s located in the lungs, helping us determine the best way to treat the disease.

Treatment
Based on diagnostic testing and a multidisciplinary evaluation, our team will develop an individualized care plan that is tailored to the specific characteristics of a patient’s disease.
Patient- and family-centered care
From evaluation to treatment to follow-up care, teamwork characterizes our program. Our medical, interventional, and surgical specialists work together at every step of care and ensure that patients and their families are informed and involved.

Chronic thromboembolic pulmonary hypertension conditions and treatments

Our specialists

No matter what disease or condition you have, Mass General Brigham has specialists near you who can help.
An illustration of a care team.
primary
phone
617-525-9733
6175259733

Contact the Chronic Thromboembolic Pulmonary Hypertension Program

Call us to speak with a team member who can help you understand your options and guide you to the care that is right for you. With locations throughout New England and support for patients traveling from outside the United States, we make it easier to access coordinated, expert care.
primary
phone
617-525-9733
6175259733
secondary
internal
International Patient Services

Contact information for international patients

/content/unified-xwalk/en/patients-visitors/international/for-patients/contact